# Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal

> **NCT00100568** · NA · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 44 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Efavirenz
- **DRUG:** Lamivudine/zidovudine

## Key facts

- **NCT ID:** NCT00100568
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2013-09-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00100568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00100568, "Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00100568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*